Summary
This 8-K filing from Intel Corporation (INTC) on October 26, 2007, announces a significant settlement agreement with Transmeta Corporation, resolving ongoing patent infringement litigation. The core of the agreement involves Intel and its customers receiving a broad, ten-year license to all current and future Transmeta patents, along with technology transfers and a non-exclusive license to Transmeta's LongRun and LongRun2 power management technologies. From an investor's perspective, this settlement removes a significant legal overhang and secures crucial patent rights for Intel and its customer base. However, the financial implications are substantial, with Intel agreeing to a total payment of $250 million over six years. A portion of this, estimated between $100 million and $150 million, is expected to be recognized as a third-quarter 2007 expense, impacting reported earnings for that period, with the remainder to be capitalized as an intangible asset. Investors should note the potential reduction in third-quarter earnings and the long-term amortization of the intangible asset.
Key Highlights
- 1Intel settles all patent infringement disputes with Transmeta Corporation.
- 2Intel and its customers secure a broad license to all current and future Transmeta patents for 10 years.
- 3Intel gains a non-exclusive license to Transmeta's LongRun and LongRun2 power management technologies and future improvements.
- 4Total settlement cost for Intel amounts to $250 million, paid over an initial lump sum and five annual installments.
- 5An estimated $100 million to $150 million of the settlement cost will be recognized as a third-quarter 2007 expense, impacting reported earnings.
- 6The remaining portion of the settlement cost will be recorded as an intangible asset and amortized over future periods.
- 7The agreement includes a general release for Intel from all Transmeta claims and dismisses all ongoing litigation.